Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Mononuclear phagocytes (monocytes, macrophages) are distributed across all body tissues and play a central role in maintaining immunologic and metabolic homeostasis. They are essential for innate host defense against infection, tissue repair and remodeling, and the antigen-specific adaptive immune response. No human has been identified as having congenital absence of this cell line, probably because macrophages are required to remove primitive tissues during fetal development as new tissues develop to replace them. Monocytes and tissue macrophages in their several forms have variable morphology, surface markers, and transcriptional profiles but common functions, particularly phagocytosis ( Table 154.1 ). Dendritic cells (DCs) are specialized derivatives of this mononuclear phagocyte system that develop from myeloid cell precursors or monocytes themselves.
Liver (Kupffer cells)
Lung (interstitial and alveolar macrophages)
Connective tissue, adipose tissue, and interstitium of major organs and skin
Serosal cavities (pleural and peritoneal macrophages)
Synovial membrane (type A synoviocytes)
Bone (osteoclasts)
Brain and retina (microglial cells)
Spleen, lymph nodes, bone marrow
Intestinal wall
Breast milk
Placenta
Granulomas (multinucleated giant cells)
Monocytes develop more rapidly during bone marrow hematopoiesis and remain longer in the circulation than do neutrophils (see Table 153.1 ). The monoblast is the first recognizable monocyte precursor, followed by the promonocyte , with cytoplasmic granules and an indented nucleus, and finally the fully developed monocyte with cytoplasmic granules filled with hydrolytic enzymes. The transition from monoblast to mature circulating monocyte requires about 6 days.
Three major subsets of human monocytes can be identified on the basis of surface antigens: CD14 ++ CD16 − classical monocytes that constitute the majority of total monocytes in the resting state; the more mature CD14 ++ CD16 + proinflammatory ( intermediate ) monocytes, which produce proinflammatory hormone-like factors termed cytokines , such as tumor necrosis factor-α (TNF-α), in response to microbial stimuli; and nonclassical ( regulatory) monocytes (CD14 + CD16 ++ ) that promote wound healing. Monocytes from these subsets migrate into tissues in response to localized inflammation or injury and provide proinflammatory host defense or antiinflammatory responses and wound healing.
Tissue (organ)-specific macrophages arise from macrophage progenitors that develop in the yolk sac and fetal liver before hematopoiesis occurs in the bone marrow. These cells maintain their population through self-renewal. Tissue macrophages can also be populated to some extent by circulating monocytes. Monocytes or macrophages at sites of active inflammation mature into proinflammatory (M1) macrophages or proresolving (M2) macrophages. In ongoing tissue injury or inflammation, many (perhaps most) of the macrophages will express a mix of the properties of the classic types.
Whether embryonic or blood derived, tissue macrophages are directed by organ-specific factors to differentiate into macrophages characteristic of that organ. Embryonic progenitors or monocytes in the liver become Kupffer cells that bridge the sinusoids separating adjacent plates of hepatocytes. Those at the lung airway surface become large ellipsoid alveolar macrophages , those in the bone become osteoclasts , and those in brain or retina become microglia . All macrophages, however, have at least 3 major functions in common: phagocytosis, presentation of antigens to lymphocytes, and enhancement or suppression of the immune response through release of a variety of potent cytokines. At sites of inflammation, monocytes and macrophages can fuse to form multinucleated giant cells ; these cells maintain the antimicrobial functions of macrophages.
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here